L-Carnitine-d9(Synonyms: (R)-Carnitine-d9; Levocarnitine-d9)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
L-Carnitine-d9 (Synonyms: (R)-Carnitine-d9; Levocarnitine-d9)

L-Carnitine-d9 (Levocarnitine-d9) 是 L-Carnitine 的氘代物。L-carnitine (Levocarnitine) 是一种参与脂肪酸代谢的内源性分子，在人体内以赖氨酸和蛋氨酸为底物进行生物合成。L-Carnitine 通过 β-氧化作用将长链脂肪酰辅酶A转运到线粒体降解。L-Carnitine 可以改善许多先天性代谢错误的代谢失衡。

L-Carnitine-d9(Synonyms: (R)-Carnitine-d9; Levocarnitine-d9)

L-Carnitine-d9 Chemical Structure

CAS No. : 126827-79-0

规格 是否有货
1 mg Check price and availability
5 mg Check price and availability

* Please select Quantity before adding items.

生物活性

L-Carnitine-d9 (Levocarnitine-d9) is the deuterium labeled L-Carnitine. L-Carnitine (Levocarnitine) is an endogenous molecule involved in fatty acid metabolism, biosynthesized within the human body using amino acids: L-lysine and L-methionine, as substrates. L-Carnitine functions to transport long chain fatty acyl-CoAs into the mitochondria for degradation by β-oxidation. L-carnitine can ameliorate metabolic imbalances in many inborn errors of metabolism[1][2].

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

170.25

Formula

C7H6D9NO3
CAS 号

126827-79-0
中文名称

左旋肉碱 d9
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. Ferreira GC, et al. L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain. Neurochem Res. 2017;42(6):1661-1675.

    [3]. Miyagawa T, et al. Effects of oral L-carnitine administration in narcolepsy patients: a randomized, double-blind, cross-over and placebo-controlled trial. PLoS One. 2013;8(1):e53707.

    [4]. Abd Eldaim MA, et al. l-Carnitine-induced amelioration of HFD-induced hepatic dysfunction is accompanied by a reduction in hepatic TNF-α and TGF-β1. Biochem Cell Biol. 2018;96(6):713-725.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务